Atlas
Back to RCM
Legal / Service Provider·RCM

Holly Buckley

Partner and Chair of the Healthcare Department at McGuireWoods LLP

Chicago, Illinois, USA

HB
Why they matter

Chairs McGuireWoods' Healthcare Department and co-chairs one of the largest healthcare PE conferences; she structures physician-practice and healthcare-services buyouts and pressure-tests the regulatory risk beneath them.

Background

Holly Buckley is a partner in McGuireWoods' Chicago office and chair of the firm's Healthcare Department. She counsels private equity funds, hospitals and health systems, physician practices, and ambulatory surgery centers on M&A structuring, regulatory due diligence, and compliance, with deep expertise in anti-kickback, Stark law, and HIPAA issues. She co-chairs the firm's Healthcare Private Equity and Finance Conference, one of the largest events in the industry.

Notable deals

  • 2022
    Led McGuireWoods team advising Assured Healthcare Partners on its partnership with Cardiovascular Health Clinic to form Cardiovascular Health Partners, a heart and vascular care platform
  • 2021
    Named a Healthcare and Life Sciences Trailblazer by the National Law Journal for deal work and leadership of the firm's Healthcare Private Equity & Finance Conference
  • 2019
    Named to Mergers & Acquisitions magazine's 'Most Influential Women in Mid-Market M&A' list of 36 honorees nationwide

Call-prep brief

Background

  • Partner in McGuireWoods' Chicago office; chairs the firm's Healthcare Department and co-chairs its Healthcare Private Equity and Finance Conference, one of the largest gatherings of healthcare PE sponsors and lenders in the U.S.
  • Practice sits at the intersection of healthcare M&A and regulation: transaction structuring, regulatory due diligence, affiliation agreements, anti-kickback and Stark law, HIPAA privacy and security.
  • Recognized by Chambers USA, Legal 500, Best Lawyers (2007-2026), NLJ Trailblazer (2021), and Mergers & Acquisitions' Most Influential Women in Mid-Market M&A (2019).

Current focus

  • Advises PE sponsors on physician practice, behavioral health, hospital, and ambulatory surgery center transactions, the provider-side ecosystem where RCM vendors sell.
  • Publishes actively on The Healthcare Investor blog and hosts the 'Across the Table' podcast; visible commentator on PE-in-healthcare trends and regulatory scrutiny of sponsor-backed roll-ups.

What they care about

  • Deal structures that survive regulatory diligence; billing and coding compliance is exactly where RCM diligence lives.
  • Building McGuireWoods' healthcare PE franchise. She values relationships with active, credible sponsors.

Sensitivities

  • She is counsel, not a banker: don't ask her to shop targets or share client-confidential pipeline. Conflicts checks may limit what she can discuss.

Questions to ask

  1. Where is regulatory diligence killing or repricing RCM and billing-adjacent deals right now?
  2. Which RCM capabilities do her provider and sponsor clients most often find missing at diligence?
  3. How is enforcement attention on PE-backed providers changing how sponsors structure RCM carve-outs and MSAs?

Outreach draft

Subject
Healthcare RCM diligence, quick perspective
Hi Holly, We're a private equity team evaluating platforms in revenue cycle management, and your vantage point as chair of McGuireWoods' Healthcare Department, and from the Healthcare Private Equity and Finance Conference, is exactly the perspective we're missing. We'd value 30 minutes on how regulatory diligence is reshaping billing-adjacent deals, and where you see compliance risk concentrating in RCM specifically. Happy to work around your schedule, and to explore whether there's a broader way to work together as we move toward a transaction. Best regards, [Your name]

Linked companies

Sources